Provided by Tiger Trade Technology Pte. Ltd.

Disc Medicine

80.94
+1.131.42%
Post-market: 80.940.00000.00%16:10 EDT
Volume:277.24K
Turnover:22.58M
Market Cap:3.11B
PE:-12.33
High:82.74
Open:79.88
Low:79.33
Close:79.81
52wk High:99.50
52wk Low:40.00
Shares:38.39M
Float Shares:32.95M
Volume Ratio:0.74
T/O Rate:0.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.5619
EPS(LYR):-6.0116
ROE:-39.08%
ROA:-23.96%
PB:4.82
PE(LYR):-13.46

Loading ...

Levi & Korsinsky Probes Disc Medicine Over Bitopertin FDA Setback

Reuters
·
Mar 05

Pomerantz Law Firm Investigates Disc Medicine for Possible Securities Fraud

Reuters
·
Mar 04

Disc Medicine Publishes Corporate Presentation on Bitopertin and Iron-Targeting Blood Disease Pipeline

Reuters
·
Mar 03

Disc Medicine Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Mar 03

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Butterfly Network (BFLY) and Disc Medicine (IRON)

TIPRANKS
·
Mar 02

Wedbush Sticks to Its Buy Rating for Disc Medicine (IRON)

TIPRANKS
·
Mar 02

U.S. RESEARCH ROUNDUP-Aardvark Therapeutics, Chevron, CrowdStrike

Reuters
·
Mar 02

Disc Medicine Implements Restructuring Following FDA Response

TIPRANKS
·
Feb 28

BRIEF-Disc Medicine's Board Approves Restructuring Plan

Reuters
·
Feb 28

Disc Medicine Inc - on Feb 26, Board Approves Restructuring Plan - SEC Filing

THOMSON REUTERS
·
Feb 28

Disc Medicine Inc - Expects Charges of About $2 Mln to Be Recorded Primarily in Q1 2026 - SEC Filing

THOMSON REUTERS
·
Feb 28

Disc Medicine CFO Jean M. Franchi Disposes of Common Shares

Reuters
·
Feb 28

Disc Medicine to Cut Workforce by 20% in Restructuring Plan

Reuters
·
Feb 28

Disc Medicine Is Maintained at Buy by Truist Securities

Dow Jones
·
Feb 28

Truist Financial Keeps Their Buy Rating on Disc Medicine (IRON)

TIPRANKS
·
Feb 27

Disc Medicine Q4 EPS $(1.62) Beats $(1.68) Estimate

Benzinga Earnings
·
Feb 27

Disc Medicine Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 26

Disc Medicine (IRON) FY 2025 net loss totals USD 212.2 million

Reuters
·
Feb 26

Disc Medicine FY Basic EPS USD -6.01 VS. Ibes Estimate USD -6.14

THOMSON REUTERS
·
Feb 26

Press Release: Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Dow Jones
·
Feb 26